
Fluconazole, the commonly used oral anti-fungal to treat vaginal yeast infections, is related to higher rates of miscarriage if used during pregnancy, according to new research published in CMAJ (Canadian Medical Association Journal).
While topical treatments are the first line for pregnant women with fungal infections, oral fluconazole is often used during pregnancy.
Advertisement
‘Safe prescribing practices should be followed strictly in pregnancy including confirming the correct diagnosis and choosing the safest medication at the lowest dose.’
Read More..
Tweet it Now
Read More..
Researchers looked at data on 441 949 pregnancies from the Quebec Pregnancy Cohort between 1998 and 2015, linking to filled prescriptions listed in the Quebec Prescription Drug Insurance database. They found that taking oral fluconazole was linked to adverse outcomes.
"Our study shows that taking any dose of oral fluconazole while pregnant may be associated with a higher chance of miscarriage," says Dr. Anick Bérard, Université de Montréal, Montréal, Quebec. "Taking higher doses of fluconazole over 150 mg in early pregnancy may be linked to a higher chance of a newborn with a heart defect."
The study is consistent with other studies, although more research is needed as the study sizes are still small.
In a related commentary http://www.cmaj.ca/lookup/doi/10.1503/cmaj.190079, Drs. Vanessa Paquette and Chelsea Elwood, British Columbia Women's Hospital and Health Centre, Vancouver, BC, write, "The study re-emphasizes safe prescribing practices in pregnancy, which include confirming the correct diagnosis and then choosing the safest medication with the largest body of data in pregnancy at the lowest appropriate doses.
Source: Eurekalert
Advertisement
The study is consistent with other studies, although more research is needed as the study sizes are still small.
In a related commentary http://www.cmaj.ca/lookup/doi/10.1503/cmaj.190079, Drs. Vanessa Paquette and Chelsea Elwood, British Columbia Women's Hospital and Health Centre, Vancouver, BC, write, "The study re-emphasizes safe prescribing practices in pregnancy, which include confirming the correct diagnosis and then choosing the safest medication with the largest body of data in pregnancy at the lowest appropriate doses.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News

Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.

Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.

Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.

Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.

In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial